Few U.S. adults diagnosed with hepatitis C virus infections receive timely treatment with antiviral drugs, the U.S. Centers for Disease Control and Prevention said on Tuesday.
The drugs cure hepatitis C in more than 95% of patients, but a study of more than 47,000 adults diagnosed in 2019 or 2020 found that only one-third of those with private insurance and one-quarter of Medicaid and Medicare recipients got one of these drugs within a year, according to a report in the CDC’s Vital Signs. Treatment rates were lowest among patients in state-administered health plans, with only 23% of Medicaid recipients and 28% of Medicare recipients receiving the drugs within a year of diagnosis, the study showed. That rate was only 35% among patients with private insurance.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Learn how to activate your Amex Bluebird Card online at bluebird.com/activate. Follow simple steps to…
Customers can pay through the app and present their digital receipt to exit the store…
Members can access their health plan benefits through mybenefits.nationsbenefits.com. The portal allows users to check…
A new lawsuit claims T-Mobile promised $200 gift cards for new lines but did not…
The IRS allows eligible families to claim a Child Tax Credit of up to $2,000…
Lloyds Bank customers faced a major app problem after a technical glitch showed other people’s…